翻訳と辞書 |
Stem Cell Theranostics : ウィキペディア英語版 | Stem Cell Theranostics
Stem Cell Theranostics is a privately held biotech company based out of Menlo Park, California that provides drug companies with a method to more accurately predict cardiotoxicity and cardiovascular drug efficacy. ==History== Stem Cell Theranostics was founded by graduate student Andrew S. Lee, Professor Joseph C. Wu, Professor Robert C. Robbins, and undergraduate student Divya Nag. It was the first med tech startup to come out of the StartX incubator program. The company uses technology developed at Stanford, to create a "clinical trial in a dish" drug screening platform, which reduces the risk of drug development. The company currently works with drug discovery and biotechnology companies to use patient-specific induced pluripotent stem cells for development of novel therapeutics.〔(【引用サイトリンク】title=The Experiment Begins: Y Combinator Admits First Biotech Startups )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Stem Cell Theranostics」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|